$DGX (Quest Diagnostics Inc.)

$DGX {{ '2015-07-23T13:23:51+0000' | timeago}} • Webcast

$DGX 2Q15 Call: Consolidated revenues of $1.93Bil, increased by 1.2% versus prior year; & grew organically by 80BP. Revenues for Diagnostic Information Services grew by 0.4% compared to prior year. Volume measured by number of requisitions declined by 0.4% versus prior year. However, revenue per acquisition was 0.9% better than the prior year.

$DGX {{ '2017-07-18T13:54:10+0000' | timeago}} • Announcement

Medical diagnostics firm $DGX has completed the acquisition of laboratory businesses Med Fusion and Clear Point. They form the basis for Quest’s first national center of excellence in precision diagnostics for oncology. The company is now a preferred provider to several organizations that are formerly owners of one or both of the acquired entities.

$DGX {{ '2017-06-27T17:25:22+0000' | timeago}} • Announcement

$DGX signed a nonbinding letter of intent to buy the outreach laboratory services business of Cape Cod Healthcare (CCHC) for undisclosed terms. Upon approval by the Massachusetts Health Policy Commission, the organizations expect to complete the transaction by Jan. 1, 2018.

$DGX {{ '2017-06-12T20:40:28+0000' | timeago}} • Announcement

$DGX to acquire two laboratory businesses in Lewisville, Texas, aiming to establish a center of excellence providing diagnostic services to aid the detection and management of cancer for oncologists and patients. Upon transaction completion, $DGX will be a preferred provider of advanced oncology diagnostics for US Oncology Network.

$DGX {{ '2017-05-16T16:20:25+0000' | timeago}} • Announcement

$DGX declared a quarterly cash dividend of $0.45 per share, payable on July 24, 2017 to shareholders of record of Quest Diagnostics common stock on July 10, 2017.

$DGX {{ '2017-04-20T14:12:14+0000' | timeago}} • Webcast

$DGX said that its partnership with their computing partner $IBM is progressing well in oncology business. The company said that it uses IBM Watson Health in the cancer treatment. $DGX believes IBM's sales force and their presence with integrated delivery systems will help the company.

$DGX {{ '2017-04-20T13:45:15+0000' | timeago}} • Webcast

$DGX said that its relationship with United Healthcare, which was announced in 4Q16, is progressing well. The company is working with United in wellness and professional laboratory services businesses. $DGX believes that its relationship with United will get stronger over time.

$DGX {{ '2017-04-20T12:38:29+0000' | timeago}} • Announcement

$DGX raised its outlook for EPS in FY17 to $4.73-4.88 from the previous guidance of $4.65-4.80. Adjusted EPS was also raised to $5.45-5.60. The upgrades reflect higher-than-expected excess tax benefit related to stock-based compensation in 1Q17.

$DGX {{ '2017-04-20T12:32:08+0000' | timeago}} • Announcement

Clinical laboratory services company $DGX posted a 2% rise in net revenue in 1Q17 to $1.89Bil. Net income attributable to $DGX was $164MM, or $1.16 per share, compared to $103MM, or $0.61 per share in the year-ago quarter. Adjusted for one-off items, EPS was $1.33.

$DGX {{ '2017-02-21T15:32:26+0000' | timeago}} • Announcement

$DGX's BoD declared a quarterly cash dividend of $0.45 per share, payable on April 19, 2017 to shareholders of record of common stock on April 5, 2017.

$DGX {{ '2017-02-16T14:08:46+0000' | timeago}} • Announcement

In an undisclosed deal, $DGX acquired outreach lab services of PeaceHealth Laboratories, a not-for-profit health system. The company will manage PeaceHealth's 11 labs, which will be owned by PeaceHealth. These labs are located within PeaceHealth's medical centers in three states. This transaction is expected to close in 2Q17.

$VCYT {{ '2017-02-09T18:03:58+0000' | timeago}} • Announcement

$VCYT said it will extend access to its Afirma Gene Expression Classifier (GEC) through an agreement with $DGX, a provider of diagnostic information services. The agreement is intended to meet growing physician demand for innovative genomic testing services to improve thyroid cancer diagnosis. $DFX is expected to begin offering the test in 2Q17.

$DGX {{ '2017-01-26T12:25:32+0000' | timeago}} • Announcement

$DGX said it expects 2017 earnings of $4.65-$4.80 per share, and adjusted diluted EPS excluding amortization in the range of $5.37-5.52. Revenue on a reported basis for 2017 is expected in the range of $7.64-7.72Bil, while cash provided by operations is expected to be approx. $1.1Bil. CapEx for 2017 is expected in the range of $250-300MM.

$DGX {{ '2017-01-26T12:21:41+0000' | timeago}} • Announcement

Healthcare company $DGX reported 4Q16 net income of $155MM, or $1.09 per share, a decline of 17.55% from $188MM, or $1.29 per share a year ago. Revenue for the quarter rose 0.64% to $1.86Bil on a reported basis, while it was up 1.9% on an equivalent basis.

$DGX {{ '2016-12-15T22:02:54+0000' | timeago}} • Announcement

$DGX said its BoD elected Stephen H. Rusckowski, the company's President and Chief Executive Officer, to serve in the additional position of Chairman of the BoD.

$DGX {{ '2016-11-21T12:37:52+0000' | timeago}} • Announcement

$DGX said it launched QuestDirect, a new Patient-Initiated Testing service. This will empower consumers who live in Colorado and Missouri to manage their health by ordering certain lab tests without a physician's order. The pilot program will be available beginning today.

$DGX {{ '2016-11-11T13:21:19+0000' | timeago}} • Announcement

$DGX reaffirmed its 2016 revenue of about $7.51Bil, an increase of 2.5% over 2015 on equivalent basis. The company projects adjusted EPS of $5.07-5.12, cash provided by operations of about $1Bil and capital expenditures of about $250MM.

$DGX {{ '2016-11-11T13:19:34+0000' | timeago}} • Announcement

$DGX's BoD increased its quarterly dividend from $0.40 to $0.45 per share. The dividend is payable on Jan. 25, 2017 to shareholders of record on Jan. 10, 2017. Additionally, the company has invested about $1Bil in 10 acquisitions since 2012.

$DGX {{ '2016-11-11T13:17:57+0000' | timeago}} • Announcement

$DGX lifted revenue growth outlook for period 2017-2020 to be 3-5%. Earnings for same period are expected to grow faster than revenue in mid-to-high single digit range. In addition, the company raised dividend by 12.5% to annual rate of $1.80 per share.

$DGX {{ '2016-10-20T20:07:04+0000' | timeago}} • Webcast

$DGX stated that its partnership with Squared is progressing. Both the companies will get benefited by integrating their laboratory clinical trial businesses. $DGX will get 40% of the equity earnings since it owns 40% of the joint venture. The company added that it will take some time to get the integration completed.

$DGX {{ '2016-10-20T19:36:29+0000' | timeago}} • Webcast

$DGX reported that some of the organic volume growth in 3Q16 was due to professional lab services business. The company is not ready to point out any specific relationship for this volume growth. More growth is expected from the professional lab services business in the immediate future, $DGX said.

Recent Transcripts

DGX (Quest Diagnostics Inc.)
Tuesday, July 25 2017 - 12:30pm
ATHN (athenahealth, Inc.)
Friday, July 21 2017 - 12:00pm
IBM (International Business Machines Corporation)
Tuesday, July 18 2017 - 9:00pm
AMS (American Shared Hospital Services)
Monday, May 15 2017 - 7:00pm
HOLX (Hologic Inc.)
Wednesday, May 10 2017 - 8:30pm
RDNT (RadNet, Inc.)
Wednesday, May 10 2017 - 2:30pm
AIQ (Alliance Healthcare Services, Inc.)
Tuesday, May 9 2017 - 9:00pm
BIOS (BioScrip, Inc.)
Thursday, May 4 2017 - 1:00pm
AGIO (Agios Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:00pm
BEAT (BioTelemetry, Inc.)
Wednesday, May 3 2017 - 9:00pm
QGEN (Qiagen NV)
Wednesday, May 3 2017 - 1:00pm
ADP (Automatic Data Processing Inc)
Wednesday, May 3 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, May 3 2017 - 12:30pm
GNMK (GenMark Diagnostics, Inc.)
Tuesday, May 2 2017 - 8:30pm
MYGN (Myriad Genetics, Inc.)
Tuesday, May 2 2017 - 8:30pm
ROP (Roper Technologies, Inc.)
Friday, April 28 2017 - 12:30pm
ATHN (athenahealth, Inc.)
Friday, April 28 2017 - 12:00pm
ACHC (Acadia Healthcare Company, Inc.)
Wednesday, April 26 2017 - 12:00pm
LH (Laboratory Corp. of America Holdings)
Tuesday, April 25 2017 - 1:00pm
CNC (Centene Corp.)
Tuesday, April 25 2017 - 12:30pm

AlphaGraphics you may like